Trial Profile
Retrospective, Observational study of ceftazidime/avibactam for the treatment of infections due to carbapenemase-producing Enterobacteriaceae
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2018
Price :
$35
*
At a glance
- Drugs Avibactam/ceftazidime (Primary)
- Indications Enterobacteriaceae infections
- Focus Therapeutic Use
- 20 Aug 2018 New trial record
- 07 Aug 2018 Results published in the Journal of Antimicrobial Chemotherapy